Status:
COMPLETED
Maintenance Effect of Clobex Shampoo on Participants With Moderate to Severe Scalp Psoriasis
Lead Sponsor:
Galderma R&D
Conditions:
Scalp Psoriasis
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
The objective of the study was to assess the maintenance effect on scalp psoriasis of Clobex® Shampoo 0.05% when used twice weekly.
Detailed Description
Psoriasis was a chronic disease that was affecting skin, the scalp and joints. Scalp psoriasis was very common and was having an important impact on people's life. Primary objective of scalp psoriasi...
Eligibility Criteria
Inclusion
- Male or female subjects aged 18 years or older.
- Subjects with moderate to severe scalp psoriasis
Exclusion
- Subjects who needed systemic treatment for their body psoriasis
- Subjects with a washout period for topical treatment(s) on the scalp less than:
- Corticosteroids 2 weeks
- All other anti-psoriasis medications 2 weeks
- Subjects with a washout period for systemic treatment(s) less than:
- PUVA therapy 4 weeks
- Biological therapies 12 weeks
- Treatments other than biologicals with a possible efficacy on psoriasis 4 weeks
- Treatment known to worsen psoriasis 2 weeks
Key Trial Info
Start Date :
September 29 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 20 2007
Estimated Enrollment :
288 Patients enrolled
Trial Details
Trial ID
NCT00400725
Start Date
September 29 2006
End Date
August 20 2007
Last Update
July 11 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
centre de Recherche Dermatologique du Québec
Québec, Canada